Patent ID: 11965039
Assignee: ZP SPV 3 K/S
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 12:
13. A compstatin analogue according to claim 1, wherein the 13-mer peptide portion (X1-X13) of the compstatin analogue has a sequence selected from the group consisting of:, (SEQ ID NO: 13)

[Sar]C(1)l[1-Me-Trp]QDWGEHRC(1)[Sar];

 

(SEQ ID NO: 14)

[Sar]C(1)l[1-Me-Trp]QDWGEHRC(1)T;

 

(SEQ ID NO: 15)

[Sar]C(1)l[1-Me-Trp]QEW[Sar]EHRC(1)T;

 

(SEQ ID NO: 16)

[Sar]C(1)l[1-Me-Trp]QEWGEHRC(1)[Sar];

 

(SEQ ID NO: 17)

[Sar]C(1)IWQDWGEHRC(1)T;

 

(SEQ ID NO: 18)

FC(1)I[1-Me-Trp]QDW[Sar]EHRC(1)[Sar];

 

(SEQ ID NO: 19)

FC(1)I[1-Me-Trp]QDW[Sar]EHRC(1)T;

 

(SEQ ID NO: 20)

FC(1)I[1-Me-Trp]QDWGEHKC(1)[Sar];

 

(SEQ ID NO: 21)

FC(1)I[1-Me-Trp]QDWGEHRC(1)[Sar];

 

(SEQ ID NO: 22)

FC(1)I[1-Me-Trp]QDWGEHRC(1)E;

 

(SEQ ID NO: 23)

FC(1)I[1-Me-Trp]QDWGEHRC(1)S;

 

(SEQ ID NO: 24)

FC(1)I[1-Me-Trp]QDWGEHRC(1)T;

 

(SEQ ID NO: 25)

FC(1)I[1-Me-Trp]QEWGEHRC(1)[Sar];

 

(SEQ ID NO: 26)

FC(1)I[1-Nal]QDWGEHRC(1)T;

 

(SEQ ID NO: 27)

FC(1)I[2-Nal]QDWGEHRC(1)T;

 

(SEQ ID NO: 28)

FC(1)IWQDWGEHRC(1)[Sar];

 

(SEQ ID NO: 29)

FC(1)IWQDWGEHRC(1)T;

 

(SEQ ID NO: 31)

IC(1)I[1-Me-Trp]QDWGEHRC(1)[Sar];

 

(SEQ ID NO: 32)

IC(1)I[1-Me-Trp]QDWGEHRC(1)T;

 

(SEQ ID NO: 33)

IC(1)I[2-Nal]QDWGEHRC(1)[Sar];

 

(SEQ ID NO: 38)

IC(1)IWQDWGEHRC(1)[Sar];

 

(SEQ ID NO: 39)

IC(1)IWQDWGEHRC(1)E;

 

(SEQ ID NO: 40)

IC(1)IWQDWGEHRC(1)S;

 

(SEQ ID NO: 41)

IC(1)IWQDWGEHRC(1)T;

 

(SEQ ID NO: 42)

IC(1)IWQDWGEHSC(1)T;

 

(SEQ ID NO: 46)

IC(1)IWQEWGEHRC(1)T;

 

(SEQ ID NO: 48)

IC(1)IWQKWGEHRC(1)T;

 

(SEQ ID NO: 49)

YC(1)I[1-Me-Trp]QDWGEHRC(1)[Sar];

 

(SEQ ID NO: 50)

YC(1)I[1-Me-Trp]QDWGEHRC(1)T;

 

(SEQ ID NO: 51)

YC(1)I[1-Me-Trp]QEWGEHRC(1)[Sar];

 

(SEQ ID NO: 52)

YC(1)I[2Nal]QDWGEHRC(1)T;

 

(SEQ ID NO: 53)

YC(1)IWQDWGEHRC(1)T;

 

(SEQ ID NO: 54)

YC(1)I[1-Me-Trp]QDWGEH[K*]C(1)[Sar]; and

and

 

(SEQ ID NO: 55)

YC(1)I[1-Me-Trp]QEW[Sar]EHRC(1)[Sar].